134 related articles for article (PubMed ID: 36357081)
21. Investigating the potential of GalR2 as a drug target for neuropathic pain.
Rich K; Rehman S; Jerman J; Wilkinson G
Neuropeptides; 2023 Apr; 98():102311. PubMed ID: 36580831
[TBL] [Abstract][Full Text] [Related]
22. Receptor for activated C kinase 1 mediates the chronic constriction injury-induced neuropathic pain in the rats' peripheral and central nervous system.
Lu R; Fan B; Yin D; Li Y; Wang B; Zhu S; Chen Y; Xu Z
Neurosci Lett; 2019 Nov; 712():134477. PubMed ID: 31491465
[TBL] [Abstract][Full Text] [Related]
23. The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain.
Hulse RP; Drake RA; Bates DO; Donaldson LF
Neurobiol Dis; 2016 Dec; 96():186-200. PubMed ID: 27616424
[TBL] [Abstract][Full Text] [Related]
24. Spinal Wnt5a Plays a Key Role in Spinal Dendritic Spine Remodeling in Neuropathic and Inflammatory Pain Models and in the Proalgesic Effects of Peripheral Wnt3a.
Simonetti M; Kuner R
J Neurosci; 2020 Aug; 40(35):6664-6677. PubMed ID: 32616667
[TBL] [Abstract][Full Text] [Related]
25. MrgC agonism at central terminals of primary sensory neurons inhibits neuropathic pain.
He SQ; Li Z; Chu YX; Han L; Xu Q; Li M; Yang F; Liu Q; Tang Z; Wang Y; Hin N; Tsukamoto T; Slusher B; Tiwari V; Shechter R; Wei F; Raja SN; Dong X; Guan Y
Pain; 2014 Mar; 155(3):534-544. PubMed ID: 24333779
[TBL] [Abstract][Full Text] [Related]
26. mTOR-neuropeptide Y signaling sensitizes nociceptors to drive neuropathic pain.
Chen L; Hu Y; Wang S; Cao K; Mai W; Sha W; Ma H; Zeng LH; Xu ZZ; Gao YJ; Duan S; Wang Y; Gao Z
JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36194480
[TBL] [Abstract][Full Text] [Related]
27. Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons.
Zhang ZJ; Cao DL; Zhang X; Ji RR; Gao YJ
Pain; 2013 Oct; 154(10):2185-2197. PubMed ID: 23831863
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1 Receptor Associated Kinase 1 Mediates the Maintenance of Neuropathic Pain after Chronic Constriction Injury in Rats.
Yin D; Chen Y; Li Y; Lu R; Wang B; Zhu S; Fan B; Xu Z
Neurochem Res; 2019 May; 44(5):1214-1227. PubMed ID: 30859436
[TBL] [Abstract][Full Text] [Related]
29. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain.
Gao YJ; Ji RR
Pharmacol Ther; 2010 Apr; 126(1):56-68. PubMed ID: 20117131
[TBL] [Abstract][Full Text] [Related]
30. Early systemic granulocyte-colony stimulating factor treatment attenuates neuropathic pain after peripheral nerve injury.
Chao PK; Lu KT; Lee YL; Chen JC; Wang HL; Yang YL; Cheng MY; Liao MF; Ro LS
PLoS One; 2012; 7(8):e43680. PubMed ID: 22937076
[TBL] [Abstract][Full Text] [Related]
31. Increased Expression of Fibronectin Leucine-Rich Transmembrane Protein 3 in the Dorsal Root Ganglion Induces Neuropathic Pain in Rats.
Yamada M; Fujita Y; Hayano Y; Hayakawa H; Baba K; Mochizuki H; Yamashita T
J Neurosci; 2019 Sep; 39(38):7615-7627. PubMed ID: 31346030
[TBL] [Abstract][Full Text] [Related]
32. cGMP produced by NO-sensitive guanylyl cyclase essentially contributes to inflammatory and neuropathic pain by using targets different from cGMP-dependent protein kinase I.
Schmidtko A; Gao W; König P; Heine S; Motterlini R; Ruth P; Schlossmann J; Koesling D; Niederberger E; Tegeder I; Friebe A; Geisslinger G
J Neurosci; 2008 Aug; 28(34):8568-76. PubMed ID: 18716216
[TBL] [Abstract][Full Text] [Related]
33. Role of the immune system in neuropathic pain.
Malcangio M
Scand J Pain; 2019 Dec; 20(1):33-37. PubMed ID: 31730538
[TBL] [Abstract][Full Text] [Related]
34. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
[TBL] [Abstract][Full Text] [Related]
35. Facilitation of neuropathic pain by the NPY Y1 receptor-expressing subpopulation of excitatory interneurons in the dorsal horn.
Nelson TS; Fu W; Donahue RR; Corder GF; Hökfelt T; Wiley RG; Taylor BK
Sci Rep; 2019 May; 9(1):7248. PubMed ID: 31076578
[TBL] [Abstract][Full Text] [Related]
36. Expression of ATP receptors in the rat dorsal root ganglion and spinal cord.
Kobayashi K; Yamanaka H; Noguchi K
Anat Sci Int; 2013 Jan; 88(1):10-6. PubMed ID: 23179910
[TBL] [Abstract][Full Text] [Related]
37. G protein-gated inwardly rectifying potassium channel subunits 1 and 2 are down-regulated in rat dorsal root ganglion neurons and spinal cord after peripheral axotomy.
Lyu C; Mulder J; Barde S; Sahlholm K; Zeberg H; Nilsson J; Århem P; Hökfelt T; Fried K; Shi TJ
Mol Pain; 2015 Jul; 11():44. PubMed ID: 26199148
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of mu-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy.
Zhang X; Bao L; Shi TJ; Ju G; Elde R; Hökfelt T
Neuroscience; 1998 Jan; 82(1):223-40. PubMed ID: 9483516
[TBL] [Abstract][Full Text] [Related]
39. Central and peripheral sites of action for CB₂ receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats.
Hsieh GC; Pai M; Chandran P; Hooker BA; Zhu CZ; Salyers AK; Wensink EJ; Zhan C; Carroll WA; Dart MJ; Yao BB; Honore P; Meyer MD
Br J Pharmacol; 2011 Jan; 162(2):428-40. PubMed ID: 20880025
[TBL] [Abstract][Full Text] [Related]
40. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions.
Verge GM; Milligan ED; Maier SF; Watkins LR; Naeve GS; Foster AC
Eur J Neurosci; 2004 Sep; 20(5):1150-60. PubMed ID: 15341587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
